Results 21 to 30 of about 2,236,849 (269)
Antimicrobial Resistance in Carbapenem resistance Pseudomonas [PDF]
Pakistan Journal of Medical and Health Sciences, 2021 Aim: To figure out the antimicrobial sensitivity effect of multidrug resistant Pseudomonas aeruginosa obtained from several type of clinical specimens. Study setting: Department of Microbiology and Resource laboratory, University of Health Sciences Lahore.
Sonia Tahir +2 more
openaire +1 more source
The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): an analysis of data from the national Antimicrobial Resistance Surveillance system [PDF]
, 2021 Background Carbapenem-resistant Acinetobacter baumannii complex (CRABC) has globally emerged as a serious public health challenge. This study aimed to describe epidemiological trends and risk factors of carbapenem resistance in A.
Ayobami, Olaniyi +5 more
core +1 more source
Carbapenem Resistance In Enterobacteriaceae [PDF]
Sohag Medical Journal, 2020 Carbapenem resistance is now a public health concern worldwide. Carbapenem is considered the last resort antimicrobial drug used for treatment of hospital care associated infection and community acquired infection that resistant to all other β-lactam drugs. There are a different mechanisms by which bacteria become resistant to carbapenem drug including
Radwa Farag +3 more
openaire +1 more source
International Journal of Infectious Diseases, 2019 Background: Bacteraemia due to carbapenem-resistant gram-negative bacteria is challenging. This study examined the burden of carbapenem and colistin resistance in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii bacteraemia in ...
A. Balkhair +7 more
doaj +1 more source
A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options
Future Science OA, 2020 Carbapenems are a class of antimicrobial agents reserved for infections caused by multidrug-resistant microorganisms. The emergence of carbapenem resistance has become a serious public health threat.
Ann A Elshamy, Khaled M Aboshanab
doaj +1 more source
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022 Introduction: Interest in fosfomycin, an old antibiotic, has been reignited because of the use of its intravenous formulation (fosfomycin sodium) in resistant infections.
Yakup GEZER +4 more
doaj +1 more source
A Selective Culture Medium for Screening Carbapenem Resistance in Pseudomonas spp.
, 2021 Purpose: The SuperCP medium containing meropenem (2 mg/L) was evaluated for screening of carbapenem-resistant Pseudomonas species. Materials and Methods: It was evaluated using 29 meropenem-susceptible and 56 meropenem-nonsusceptible Pseudomonas-like ...
Nordmann, P., Poirel, L., Fournier, C.
core +1 more source
Management of carbapenem-resistant Enterobacteriaceae infections [PDF]
Clinical Microbiology and Infection, 2019 Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele +2 more
openaire +3 more sources
Antimicrobial resistance surveillance in Europe 2013: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) [PDF]
, 2014 Portugal - EARS-Net Management Team & National representatives of EARS-Net (Manuela Caniça, José Artur Paiva, Vera Manageiro, Eugénia Ferreira)The results presented in this report are based on antimicrobial resistance data from invasive isolates reported
European Antimicrobial Resistance Surveillance Network (EARS-Net)
core +1 more source
Carbapenem-resistant genes primer sets.
, 2023 BackgroundCarbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge due to the high morbidity and mortality associated with their ...
Frank Twum Aboagye (17304867) +3 more
core +1 more source